Hemolytic anemia is how to return a responsibility
summary
Hemolytic anemia is a kind of anemia that occurs after the destruction of human red blood cells is accelerated and the hemopoietic function of bone marrow is insufficient. The average survival time of human normal red blood cells is 120 days, and the survival time of hemolytic anemia patients will be shortened, usually less than 15-20 days. For some reasons, hemolytic anemia occurs when the compensatory increase of bone marrow is insufficient to make up for the destruction of red blood cells. This is hemolytic anemia. There are many causes of hemolytic anemia. Here's how hemolytic anemia is going on.
Hemolytic anemia is how to return a responsibility
First: Although there are many causes of hemolytic anemia, the pathogenesis is not the same. But generally speaking, it can be divided into two types, namely, the factors of red blood cells themselves and the external factors of red blood cells. Red blood cell's own factor: mostly is because the red blood cell itself heredity intrinsic flaw causes.
Second, the external factors of red blood cells: immune factors. It is because some external factors (such as drugs) stimulate the body to produce antibodies against red blood cells. After the antibodies combine with red blood cells, the red blood cell membrane is easy to damage, causing anemia. Biological factors. Chemical factors. Some chemicals and drugs can damage red blood cells.
Third, physical factors. Large area burns, ionizing radiation and so on can change the morphology and fragility of red blood cells, which is easy to damage. Hypersplenism can enhance the retention of blood cells, resulting in excessive destruction of red blood cells and anemia. Such as cirrhosis, hypersplenism patients with anemia is such a situation. According to the type of hemolysis and etiology to determine the treatment.
matters needing attention
Infection itself can cause hemolysis, and it can also cause acute hemolytic crisis in patients with original hemolytic diseases, so we should pay attention to the prevention and treatment of infection; hemolysis secondary to other diseases should be actively treated.